Texas Rescinds Cresco Labs' TCUP License Over Scoring Error

A high-profile shake-up has hit the Texas medical cannabis market just six weeks after the state announced its first major expansion in years. The Texas Department of Public Safety (DPS) has rescinded the conditional Texas Compassionate Use Program (TCUP) license previously awarded to Cresco Labs, citing a "tabulation error" in how applicant scores were calculated. Two other operators originally selected on April 1, 2026, lost their conditional awards under the same review.

For patients in the country's second-most-populous state — and for the multi-state operators (MSOs) racing to plant a flag in Texas — the reversal is a sharp reminder that even celebratory license announcements remain reversible until they are activated.

What Happened: The TCUP Tabulation Error

In early April 2026, DPS announced the latest round of conditional TCUP licenses, awarding slots to Chicago-based MSO Cresco Labs and two other applicants. The expansion was the most meaningful enlargement of the Texas medical cannabis program since its launch and was widely viewed as a turning point for patient access in a state where supply has been chronically short.

Roughly a month later, DPS disclosed that it had identified an error in how the agency tabulated scores across the application pool. Under the corrected scoring, three different applicants — Bayou City Medical Dispensary, Sawtooth Texas LLC, and Bluebonnet Technologies, LLC — now qualify for the conditional awards. The previously announced winners, including Cresco Labs Texas LLC, have been moved to a backup eligibility list and would only receive a conditional license if one of the new top-three applicants fails to meet program requirements.

In its own update, Cresco Labs confirmed that the company had been notified of the rescission and said it is "evaluating its options." For now, the conditional license that the company publicly celebrated in early April no longer exists.

Why TCUP Is the Most Watched Medical Program in the South

The Texas Compassionate Use Program is unusual among medical cannabis frameworks for two reasons. First, qualifying products are tightly capped on tetrahydrocannabinol (THC) content under state law, with delivery limited to a small number of vertically integrated licensees who must control cultivation, processing, and distribution under one roof. Second, the state has historically capped the number of licensees at a level that many patient advocates argued was far too low for a state with more than 30 million residents.

The 2026 expansion was supposed to widen the pipeline — adding processing capacity, opening new patient pickup points, and reducing the long drive times that have plagued patients in West Texas, the Panhandle, and the Rio Grande Valley. With three of the most prominent winners now back on a waitlist, the practical effect is to slow that buildout while the agency stabilizes its license decisions. Patients searching for their nearest currently-active TCUP pickup site can use Budpedia's Texas dispensaries directory for verified hours and product menus.

What the Reversal Means for Patients

For Texans living with qualifying conditions — epilepsy, post-traumatic stress disorder, autism, terminal cancer, and a growing list of others — the immediate impact is uncertainty. Existing TCUP licensees can continue to serve patients without disruption, and DPS has not signaled that pickup points or product registrations approved under the prior winners will be invalidated. However, the buildout of additional dispensing sites tied to the rescinded awards is on pause until the corrected awardees finalize their applications.

Patient advocates have pushed for a stable license framework precisely because supply hiccups disproportionately hurt the most vulnerable users, including children with intractable epilepsy and veterans with PTSD. The TCUP reversal will likely renew calls in the Texas Legislature to codify a more transparent scoring process and provide a backstop against administrative errors.

What It Means for Multi-State Operators

For MSOs, the Cresco Labs episode highlights a category of risk that does not show up cleanly on quarterly earnings calls: "conditional license risk." A conditional award is not the same as an operational license. It is contingent on satisfying program requirements, paying fees, and surviving the kind of administrative review that just unfolded in Texas.

The market reaction has been measured but pointed. Industry analysts have flagged the Texas reversal in operator due diligence checklists, noting that announcement-stage licenses should be discounted relative to fully issued operating licenses when modeling pipeline value. For MSOs whose growth strategies depend on stacking new state wins on top of legacy markets, the lesson is that a celebration in April can become a clarification in May.

For Cresco Labs specifically, Texas was a meaningful potential growth lane in a year when many MSOs are leaning into limited-license states to offset price compression in more saturated adult-use markets. The company has not provided a definitive next step beyond saying it is evaluating its options, which could include legal challenge, refiling for future rounds, or shifting capital toward other expansion targets.

How the New Top Three Got There

Under the corrected tabulation, three Texas-affiliated applicants now hold conditional positions: Bayou City Medical Dispensary, Sawtooth Texas LLC, and Bluebonnet Technologies, LLC. While each will need to satisfy DPS requirements before becoming operational, their elevation suggests a recalibration toward in-state applicants in a program that has historically been dominated by larger, multi-state operators.

That dynamic matters for the texture of the Texas market. A bench of in-state operators tends to localize supply chains, hire locally, and build relationships with Texas physicians and patient groups, all of which can shorten the path from conditional approval to operational dispensing.

What Comes Next for TCUP

Several near-term milestones are worth watching:

The corrected awardees will move through the rest of the conditional licensure process, including facility inspections, security plan reviews, and the standing-up of TCUP-compliant cultivation and distribution. Each step is a potential point of delay.

DPS may publish more detailed guidance on its scoring methodology and the safeguards added after the tabulation error. Patient advocates and applicants alike have called for an end-to-end audit and a public-facing scoring rubric.

A 2027 legislative session in Texas is already shaping up to include cannabis on its agenda, with proposals likely to expand qualifying conditions, raise THC caps, and rethink how license caps are set. The TCUP reversal will be part of the backdrop for those debates.

What This Says About the Broader Cannabis Licensing Landscape

The Cresco Labs reversal is the latest reminder that 2026 is a licensing-heavy year across U.S. cannabis markets. From Schedule III implementation at the federal level to DEA registrations for state-licensed medical operators, this year's regulatory calendar is dense with administrative decisions whose downstream effects on supply, pricing, and access can be significant.

Investors, operators, and patients are all learning to differentiate between three license states: announced, conditional, and operational. The closer a license sits to "operational," the more durable it tends to be. Announcements that get reversed weeks later — as in Texas — sit on the most fragile end of the spectrum.

Key Takeaways

• Texas DPS rescinded three TCUP conditional licenses in May 2026, including the high-profile award to Cresco Labs, citing a tabulation error in the original scoring.
• Three Texas-affiliated applicants — Bayou City Medical Dispensary, Sawtooth Texas LLC, and Bluebonnet Technologies — now hold the corrected conditional positions.
• The reversal delays the buildout of the Texas medical cannabis expansion but does not affect existing TCUP licensees.
• The episode underscores conditional-license risk for MSOs and may prompt new legislative scrutiny of state cannabis licensing procedures.

Tracking TCUP rollout? Budpedia's cannabis dispensary directory keeps verified hours, menus, and physician resources up to date for every Texas pickup point. For more on the state's evolving cannabis law landscape, see our Texas smokable-hemp ban legal challenge coverage.